NSI-566

 

Posted on Tuesday, January 13, 2015 - 12:04, By: Margaret Wahl
Update (March 17, 2015): Neuralstem announced on March 12, 2015, that a phase 2 trial to test transplantation into the spinal cord of its NSI-566 neural stem cells showed the procedure was generally safe and well tolerated in 15 ALS patients (with one exception) and that stabilization or...

Data from Neuralstem’s completed phase 1 trial of neural stem cells in ALS showed safety and tolerability in all, evidence of a ‘treatment effect’ in some

Posted on Friday, October 12, 2012 - 10:53, By: Amy Madsen
Results from a completed phase 1 trial of neural stem cells in people with amyotrophic lateral sclerosis (ALS) show that the stem cells and the surgical method used to transplant them were safe and well-tolerated. In addition, the experimental therapy appears to have "interrupted the progression of...

Advertisements

myMuscleTeam